Levalbuterol

Levalbuterol - a short acting sympathomimetic beta 2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol binds to beta 2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (atp) to cyclic 3',5' adenosine monophosphate (camp).

Mechanism of action[edit | edit source]

Increased camp levels lead to the activation of protein kinase a, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased camp concentrations also inhibit the release of inflammatory mediators, especially from mast cells.

Resources[edit source]

Latest articles - Levalbuterol

This medical article is a stub. You can help WikiMD by expanding it.

‎ Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Levalbuterol for any updates.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.